What is the most likely differential diagnosis for persistent hypoglycemia?

Differential Diagnosis of Persistent Hypoglycemia

In non-diabetic patients with persistent hypoglycemia, the top differential diagnoses are insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS), insulin autoimmune syndrome (Hirata's disease), factitious hypoglycemia from exogenous insulin or sulfonylurea use, non-islet cell tumors, and endocrine deficiencies (adrenal insufficiency or hypopituitarism). 1

Initial Diagnostic Requirement

Before pursuing any differential diagnosis, you must document Whipple's triad in all cases 2, 3:

• Symptoms or signs consistent with hypoglycemia (shakiness, confusion, tachycardia, sweating, irritability, hunger) 4
• Documented low plasma glucose concentration (<70 mg/dL or <3.9 mmol/L) 4, 3
• Resolution of symptoms after glucose administration 2, 3

Algorithmic Approach to Differentiation

Step 1: Rule Out Obvious Causes First

Medication-induced hypoglycemia is the most common cause overall, though typically seen in diabetic patients 3:

• Exogenous insulin administration 1
• Sulfonylureas or meglitinides 4, 3
• Screen plasma and urine for oral hypoglycemic agents 1, 3

Critical illness and organ failure 1, 3:

• End-stage kidney disease (eGFR <60 mL/min/1.73 m²) 4
• Severe hepatic dysfunction 3
• Sepsis or critical illness 1

Hormone deficiencies 1, 3:

• Primary adrenal insufficiency 1
• Hypopituitarism 1

Step 2: Laboratory Evaluation During Hypoglycemia

For fasting hypoglycemia, perform a supervised 72-hour fast with measurement of 1, 3:

• Plasma glucose
• Insulin
• C-peptide
• Proinsulin
• β-hydroxybutyrate
• Plasma/urine sulfonylurea screen 1
• Anti-insulin antibodies 2, 3

For postprandial symptoms, a mixed meal test is preferable 1

Step 3: Interpret Laboratory Patterns

Elevated insulin with elevated C-peptide indicates endogenous hyperinsulinism 1, 3:

• Insulinoma: Most common cause of endogenous hyperinsulinemic hypoglycemia; elevated insulin, C-peptide, and proinsulin with suppressed β-hydroxybutyrate 1
• NIPHS (nesidioblastosis): Postprandial hypoglycemia with similar biochemical pattern but negative imaging for discrete tumor 2, 1

Elevated insulin with suppressed C-peptide indicates exogenous insulin administration 1, 3:

• Factitious hypoglycemia from surreptitious, accidental, or malicious insulin use 1, 3
• Consider psychiatric evaluation in cases of suspected factitious disorder 1

Elevated insulin with elevated C-peptide AND positive anti-insulin antibodies 2, 3:

• Insulin autoimmune syndrome (Hirata's disease): Rare condition with autoantibodies binding endogenous insulin 2, 1

Suppressed insulin with elevated insulin-like growth factor II 1:

• Non-islet cell tumor hypoglycemia: Large mesenchymal or epithelial tumors producing IGF-II 1

Common Pitfalls to Avoid

Do not pursue extensive workup without documented Whipple's triad 3:

• Hypoglycemic symptoms are common and nonspecific 2
• Many patients report symptoms without true biochemical hypoglycemia 2

Timing of laboratory collection is critical 1, 3:

• Samples must be drawn during symptomatic hypoglycemia, not retrospectively 3
• A glucose level <55 mg/dL during supervised fast is typically sufficient to obtain diagnostic samples 1

Consider factitious causes before invasive procedures 1, 3:

• Always screen for sulfonylureas and measure C-peptide to distinguish exogenous from endogenous insulin 1, 3
• Patients with mental health issues may present with factitious hypoglycemia that can obscure organic causes 1

Risk Stratification Context

While the question addresses non-diabetic hypoglycemia, recognize that recurrent level 2 hypoglycemia (<54 mg/dL) or level 3 hypoglycemia (requiring assistance) constitutes an urgent medical issue requiring immediate intervention 4. Major risk factors in any population include recent severe hypoglycemia, impaired hypoglycemia awareness, end-stage kidney disease, and cognitive impairment 4.